Study on serum and urine microbiota in patients with PSA in the gray zone

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400093612

Enrollment

Unknown

Registered

2024-12-09

Start date

2023-11-30

Completion date

Unknown

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

PCa group:none

BPH group:none

Eligibility

Sex/Gender

All

Age

40 Years to 95 Years

Inclusion criteria

Inclusion criteria: Patients with an outpatient diagnosis of elevated PSA

Exclusion criteria

Exclusion criteria: 1. Patients with retested PSA values outside 4-10ng/ml range after admission were excluded; 2. Patients who had used antibiotics in the past 3 months were excluded; 3. Patients with urinary tract infection were excluded; 4. Patients with other tumors were excluded; 5. Patients who dropped out of the study were excluded.

Design outcomes

Primary

Measure	Time frame
Total Prostate Specific Antigen;Urine microbiota 5R16S test results;Serum protein test results;Serum metabolite test results;	—

Countries

China

Contacts

Public ContactNinghan Feng

Jiangnan University Medical Center

n.feng@njmu.edu.cn+86 138 6189 2528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026